Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-014862
Filing Date
2024-11-07
Accepted
2024-11-07 16:06:40
Documents
84
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rigl-20240930x10q.htm   iXBRL 10-Q 2539947
2 EX-10.1 rigl-20240930xex10d1.htm EX-10.1 592286
3 EX-10.2 rigl-20240930xex10d2.htm EX-10.2 194358
4 EX-10.3 rigl-20240930xex10d3.htm EX-10.3 124461
5 EX-31.1 rigl-20240930xex31d1.htm EX-31.1 15899
6 EX-31.2 rigl-20240930xex31d2.htm EX-31.2 16785
7 EX-32.1 rigl-20240930xex32d1.htm EX-32.1 9081
8 GRAPHIC rigl-20240930x10q007.jpg GRAPHIC 90595
9 GRAPHIC rigl-20240930xex10d2001.jpg GRAPHIC 7926
  Complete submission text file 0001558370-24-014862.txt   10745006

Data Files

Seq Description Document Type Size
10 EX-101.SCH rigl-20240930.xsd EX-101.SCH 59000
11 EX-101.CAL rigl-20240930_cal.xml EX-101.CAL 61911
12 EX-101.DEF rigl-20240930_def.xml EX-101.DEF 221689
13 EX-101.LAB rigl-20240930_lab.xml EX-101.LAB 489680
14 EX-101.PRE rigl-20240930_pre.xml EX-101.PRE 367444
87 EXTRACTED XBRL INSTANCE DOCUMENT rigl-20240930x10q_htm.xml XML 1725193
Mailing Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-624-1100
RIGEL PHARMACEUTICALS INC (Filer) CIK: 0001034842 (see all company filings)

EIN.: 943248524 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-29889 | Film No.: 241435580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)